Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.070
-0.050 (-4.46%)
At close: Sep 18, 2026, 4:00 PM EDT
1.100
+0.030 (2.80%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $3.82 million as of September 18, 2026. Its market cap has decreased by -85.25% in one year.
Market Cap
3.82M
Enterprise Value
1.43M
1-Year Change
-85.25%
Ranking
Category
Stock Price
$1.07
ChartMarket Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $3.82M, a decrease of -93.44%. That is a compound annual growth rate of -52.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.82M | -75.92% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 4.22M |
| Mustang Bio | 4.09M |
| Calidi Biotherapeutics | 4.06M |
| PMGC Holdings | 3.87M |
| Jupiter Neurosciences | 3.77M |
| Revelation Biosciences | 3.71M |
| HCW Biologics | 3.43M |
| BioRestorative Therapies | 3.43M |